(Date:11/21/2008)...Newswire/ -- NursingCenter.com, the premier site,...eviewed content, has been,updated to improve the ...,users. Powered by Lippincott Williams & Wilki... peer-reviewed continuing education activities and... leading nursing journals.,Lippincott Williams &a...
(Date:11/21/2008).... 21 Today, prescription...on in treating 88 percent of patients suffering ch...ated for a chronic condition account for 96 percen... of all medical costs. A proprietary new pharmacy...Solutions, Inc. (NYSE: MHS ) significantly reduc...
(Date:11/21/2008)...deadly diseaseits cause remains a mysteryswept int...with citizens, soldiers and refugees of the war th...lled with corpses, social order broke down. Over t...d Athens lost a third of its population. It lost t...ing of the end of the Golden Age of Greece. , T...
(Date:11/21/2008)...Newswire-FirstCall/ -- Symmetry Medical Inc. (NYSE...cts to the global orthopedic device industry and o.... Moore, President and Chief Executive Officer, an...nancial Officer, are scheduled to present at the 2... The New York Palace Hotel on Wednesday, December ...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4...ollege and hospital was a scene of pandemonium wit...octors initiating an outpatients’ department// on ...ents. The groups, under the name of ‘Youth for equ...ents have expressed consolation at the opening of ...
... to a recent survey it was found that people who w...cious about the way they look//. This resulted in ...TV programmes have also played their parts in crea... surgeries. Statistics show that there is a 40 % ...
... to a research it was found that radiotherapy give...ective against breast cancer//. The researchers fr...to be effective in the recurrence of cancer when c...ses. The findings were as a result of the 10-year ...
...study, Roche Holding AG (RHHBY), a Swiss pharmaceu...eases when Herceptin was added to hormonal therapy...-positive, as well as HER2-positive, this combined...receptor-positive breast cancer results lower risk...
Other Medicine News:(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)...on Payment from Roche- , , MONTVALE, N.J., ...ticals Corp. (Nasdaq: MEMY ) today announced tha...e 2 trial of R3487/MEM 3454, its lead alpha-7 nico...sociated with schizophrenia (CIAS). The Company h...riggering a $5.0 million payment from its partner ...
(Date:11/18/2008)...ciation,s 2008 Faces of Influenza survey underscor...inst influenza; Mother and Gold Medalist Kristi Ya...ov. 18 While 78 percent of mothers...and potentially life-threatening disease that can ...milies will get vaccinated this season, according ...
(Date:11/12/2008)... 12 A new study being,p...ill help answer the,question, what causes Parkinso...in the medical research into,Parkinson,s disease i...die,in the first place. Answering this question ha...nearly identical types of brain cells that produce...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 1Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 3Jingle bells not merry for tone deaf individuals 1679 1Jingle bells not merry for tone deaf individuals 1679 2Jingle bells not merry for tone deaf individuals 1679 3Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 1Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 2Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 3St Jude finds link between cellular defense processes showing how cancer cells survive 8556 1St Jude finds link between cellular defense processes showing how cancer cells survive 8556 2St Jude finds link between cellular defense processes showing how cancer cells survive 8556 3... /PRNewswire-FirstCall/ --,Medivation, Inc. today ...ed, double-blinded, placebo-controlled Phase 2 eff...o-moderate Alzheimer,s,disease demonstrated that p...proved compared to patients taking placebo on all,...gnitive function,memory, ability to perform tasks...
... of Enzyme Substrate, CRANBURY, N.J., March 19, 20...aceutical company developing,small-molecule, orall...treatment of human genetic diseases, announced tod...ies of Amigal(TM) (migalastat,hydrochloride, AT100...ent of Fabry disease, at the of Medical Genetics (...
Other Medicine Technology:Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 2Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 3Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 4Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 2Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 3...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: